BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32483203)

  • 21. Differentially expressed lncRNAs in peripheral blood mononuclear cells from middle-aged female patients with rheumatoid arthritis-associated interstitial lung disease.
    Zhou W; Zheng J; Yuan M; Yuan L; Jia X; Liu H
    Clin Rheumatol; 2020 Aug; 39(8):2281-2289. PubMed ID: 32133566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis.
    Hruskova V; Jandova R; Vernerova L; Mann H; Pecha O; Prajzlerova K; Pavelka K; Vencovsky J; Filkova M; Senolt L
    Arthritis Res Ther; 2016 Jun; 18(1):124. PubMed ID: 27255643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis.
    Anderson AE; Maney NJ; Nair N; Lendrem DW; Skelton AJ; Diboll J; Brown PM; Smith GR; Carmody RJ; Barton A; Isaacs JD; Pratt AG
    Rheumatology (Oxford); 2019 Jul; 58(7):1250-1258. PubMed ID: 30753680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis.
    van Baarsen LG; Bos WH; Rustenburg F; van der Pouw Kraan TC; Wolbink GJ; Dijkmans BA; van Schaardenburg D; Verweij CL
    Arthritis Rheum; 2010 Mar; 62(3):694-704. PubMed ID: 20131234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
    Kudo-Tanaka E; Ohshima S; Ishii M; Mima T; Matsushita M; Azuma N; Harada Y; Katada Y; Ikeue H; Umeshita-Sasai M; Miyatake K; Saeki Y
    Clin Rheumatol; 2007 Oct; 26(10):1627-33. PubMed ID: 17286215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.
    Reynier F; Petit F; Paye M; Turrel-Davin F; Imbert PE; Hot A; Mougin B; Miossec P
    PLoS One; 2011; 6(10):e24828. PubMed ID: 22043277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical prediction rule combining routine assessment and power Doppler ultrasonography for predicting progression to rheumatoid arthritis from early-onset undifferentiated arthritis.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Filippucci E; Grassi W
    Clin Exp Rheumatol; 2010; 28(5):686-94. PubMed ID: 20822707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
    Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
    Front Immunol; 2019; 10():1353. PubMed ID: 31249576
    [No Abstract]   [Full Text] [Related]  

  • 30. A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis.
    Rodríguez-Muguruza S; Altuna-Coy A; Castro-Oreiro S; Poveda-Elices MJ; Fontova-Garrofé R; Chacón MR
    Front Immunol; 2021; 12():790880. PubMed ID: 34868079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
    Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
    Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
    Ciechomska M; Bonek K; Merdas M; Zarecki P; Swierkot J; Gluszko P; Bogunia-Kubik K; Maslinski W
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):389-397. PubMed ID: 29744553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Voskuyl AE; Rustenburg F; Baggen JM; Ibrahim SM; Fero M; Dijkmans BA; Tak PP; Verweij CL
    Ann Rheum Dis; 2007 Aug; 66(8):1008-14. PubMed ID: 17223656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.
    Singh A; Patro PS; Aggarwal A
    Clin Rheumatol; 2019 Mar; 38(3):877-884. PubMed ID: 30511295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification and validation of novel biomarkers for cold-dampness syndrome of rheumatoid arthritis based on integration of multiple bioinformatics methods].
    Li T; Chen WJ; Zhang YQ; Liu W; Lin N; Liu XT
    Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6721-6729. PubMed ID: 38212032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes.
    de Jong TD; Lübbers J; Turk S; Vosslamber S; Mantel E; Bontkes HJ; van der Laken CJ; Bijlsma JW; van Schaardenburg D; Verweij CL
    Arthritis Res Ther; 2016 Jul; 18():165. PubMed ID: 27411379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study.
    Nakamura S; Suzuki K; Iijima H; Hata Y; Lim CR; Ishizawa Y; Kameda H; Amano K; Matsubara K; Matoba R; Takeuchi T
    Arthritis Res Ther; 2016 Jul; 18():159. PubMed ID: 27435242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of interleukin-37 in patients with rheumatoid arthritis.
    Yuan ZC; Wang JM; Huang AF; Su LC; Li SJ; Xu WD
    Int J Rheum Dis; 2019 Jun; 22(6):1123-1129. PubMed ID: 30843355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters.
    de Jong TD; Blits M; de Ridder S; Vosslamber S; Wolbink G; Nurmohamed MT; Verweij CL
    Arthritis Res Ther; 2016 Dec; 18(1):290. PubMed ID: 27955694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.
    Alivernini S; Bruno D; Tolusso B; Bui L; Petricca L; Gigante MR; Birra D; Fedele AL; Peluso G; Federico F; Ferraccioli G; Gremese E
    Arthritis Res Ther; 2019 May; 21(1):116. PubMed ID: 31072400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.